Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

•There has been concern for worsening antimicrobial resistance in COVID-19 patients.•The choice of antibiotics in COVID-19 patients is often empiric.•The guidelines on antibiotic use in COVID-19 should be adapted to new evidence.•Infection prevention control policies can reduce antimicrobial resistance.•Antimicrobial stewardship programs can contribute to limiting antimicrobial resistance.